Document is current

Article History

Received: 31 May 2023

Accepted: 20 July 2023

First Online: 2 August 2023

Declarations

:

: As this was a database study, no patients were enrolled, and no ethics approval was required.

: N/A.

: LCIV has received personal compensation for serving as a consultant and/or advisor for Allergan/AbbVie, Amneal, Biohaven, Haleon, LinPharma, Satsuma, and Teva; was on the advisory panel for Ctrl M Health (stock); received grant/research support from the Disparities in Headache Advisory Council and Amgen. He has received CME honoraria from American Headache Society, American Academy of Neurology, BrainWeekend, NeurologyWeek, and Migraine360 CME Program. He receives a salary as faculty from Michigan State University College of Human Medicine and Thomas Jefferson University. He is a non-compensated associate editor for Headache: The Journal of Head and Face Pain and serves as a non-compensated Board Member-at-Large for the Clinical Neurological Society of America. BT, CS, CA, SK, SAR, and SSB are all full-time employees of Lundbeck. SJN has received honoraria for consulting from Allergan/AbbVie, Amgen/Novartis, Axsome, BioDelivery Sciences, Biohaven, Eli Lilly, Fenix Group International, Teva Pharmaceuticals, and Theranica. She has received honoraria for speaking from Allergan/AbbVie, Amgen/Novartis, Eli Lilly, and Teva Pharmaceuticals (all inactive at the time of this publication). She has received honoraria for work in education or publishing from the American Academy of Neurology, the American Headache Society, Evolve Med Ed, the Massachusetts Medical Society, MedLink Neurology, MJH Life Sciences, NACCME, Neurology Learning Network, Pennsylvania Neurologic Society, Springer, WebMD/Medscape, and Wolters-Kluwer and has received legal fees for serving as a medical expert to Jackson & Campbell.